Asahi Kasei Medical contributed to a round that took the total raised by the microbial detection technology provider past $255m.

Rapid Micro Biosystems, a US-based provider of microbial detection systems, closed a $120m financing round yesterday that included Asahi Kasei Medical, the medical products subsidiary of chemicals producer Asahi Kasei. Healthcare investment group Ally Bridge Group led the round, which also featured Bain Capital Life Sciences, a subsidiary of private equity firm Bain Capital, in…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.